Skip to main content

Advertisement

SpringerLink
Log in

Non-motor symptoms in Chinese Parkinson’s disease patients with and without LRRK2 G2385R and R1628P variants

  • Neurology and Preclinical Neurological Studies - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

Non-motor symptoms (NMS) are common among patients with Parkinson’s disease (PD). However, reports on NMS in Chinese PD population are scarce. Little is known about NMS in patients with Asian specific leucine-rich repeat kinase 2 (LRRK2) variants in G2385R and R1628P. This study aimed to elucidate the clinical characteristics of NMS in Chinese PD patients and to ascertain if there were differences in NMS between PD patients with and without LRRK2 variants. A multicenter, observational study was conducted with 1,225 sporadic PD (sPD) patients recruited from a PD cohort of the Chinese National Consortium on neurodegenerative diseases, 163 participants had the LRRK2 variants. The Non-motor Symptom Questionnaire (NMSQ) was used to screen for the presence of NMS. This study found the majority of sPD patients (97.6 %) had at least one NMS. A mean of 8.72 NMS (SD = 5.43) was reported per patient. Forgetfulness, constipation and daytime sleepiness were found to be the most frequent NMS. Moreover, the number of NMS was positively correlated with the age, disease duration, Hoehn & Yahr stage and the motor scores of the unified Parkinson’s disease rating scale. Although no discrepancy was found in the number of NMS between sPD patients with and without LRRK2 variants, nocturia was less common in LRRK2 variants carriers than in non-carriers (P = 0.045). NMS appear to be prevalent in Chinese sPD population. There are no differences in the NMS phenotype between LRRK2 and no LRRK2 patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bardien S, Lesage S, Brice A et al (2011) Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson’s disease. Parkinsonism Relat Disord 17:501–508

    Article  PubMed  Google Scholar 

  • Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24:1641–1649

    Article  PubMed  Google Scholar 

  • Chaudhuri KR, Martinez-Martin P, Schapira AH et al (2006a) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923

    Article  PubMed  Google Scholar 

  • Chaudhuri KR, Healy DG, Schapira AH (2006b) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5:235–245

    Article  PubMed  Google Scholar 

  • Chaudhuri KR, Prieto-Jurcynska C, Naidu Y et al (2010) The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 25:704–709

    Article  PubMed  Google Scholar 

  • Chen W, Xu ZM, Wang G et al (2012) Non-motor symptoms of Parkinson’s disease in China: a review of the literature. Parkinsonism Relat Disord 18:446–452

    Article  PubMed  Google Scholar 

  • Cornu JN, Abrams P, Chapple CR et al (2012) A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management—a systematic review and meta-analysis. Eur Urol 62:877–890

    Article  PubMed  Google Scholar 

  • Correia Guedes L, Ferreira JJ, Rosa MM et al (2010) Worldwide frequency of G2019S LRRK2 mutation in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord 16:237–242

    Article  CAS  PubMed  Google Scholar 

  • Farrer MJ, Stone JT, Lin CH et al (2007) LRRK2 G2385R is an ancestral risk factor for Parkinson’s disease in Asia. Parkinsonism Relat Disord 13:89–92

    Article  PubMed  Google Scholar 

  • Gaig C, Marti MJ, Ezquerra M et al (2007) G2019S LRRK2 mutation causing Parkinson’s disease without Lewy bodies. J Neurol Neurosurg Psychiatry 78:626–628

    Article  PubMed Central  PubMed  Google Scholar 

  • Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39

    Article  CAS  PubMed  Google Scholar 

  • Healy DG, Falchi M, O’Sullivan SS et al (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: a case-control study. Lancet Neurol 7:583–590

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Huang Y, Halliday GM, Vandebona H et al (2007) Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson’s disease. Mov Disord 22:982–989

    Article  PubMed  Google Scholar 

  • Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Khoo TK, Yarnall AJ, Duncan GW et al (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80:276–281

    Article  PubMed Central  PubMed  Google Scholar 

  • Litvan I, Bhatia KP, Burn DJ et al (2003) Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467–486

    Article  PubMed  Google Scholar 

  • Lu CS, Wu-Chou YH, van Doeselaar M et al (2008) The LRRK2 Arg1628Pro variant is a risk factor for Parkinson’s disease in the Chinese population. Neurogenetics 9:271–276

    Article  CAS  PubMed  Google Scholar 

  • Mariappan P, Turner KJ, Sothilingam S et al (2007) Nocturia, nocturia indices and variables from frequency-volume charts are significantly different in Asian and Caucasian men with lower urinary tract symptoms: a prospective comparison study. BJU Int 100:332–336

    Article  PubMed  Google Scholar 

  • Marras C, Schule B, Munhoz RP et al (2011) Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology 77:325–333

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Marti-Masso JF, Ruiz-Martinez J, Bolano MJ et al (2009) Neuropathology of Parkinson’s disease with the R1441G mutation in LRRK2. Mov Disord 24:1998–2001

    Article  PubMed  Google Scholar 

  • Martinez-Martin P, Schapira AH, Stocchi F et al (2007) Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629

    Article  PubMed  Google Scholar 

  • Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM et al (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord 26:399–406

    Article  PubMed  Google Scholar 

  • Romenets SR, Wolfson C, Galatas C et al (2012) Validation of the non-motor symptoms questionnaire (NMS-Quest). Parkinsonism Relat Disord 18:54–58

    Article  PubMed  Google Scholar 

  • Ross OA, Wu YR, Lee MC et al (2008) Analysis of LRRK2 R1628P as a risk factor for Parkinson’s disease. Ann Neurol 64:88–92

    Article  CAS  PubMed  Google Scholar 

  • Silveira-Moriyama L, Guedes LC, Kingsbury A et al (2008) Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 71:1021–1026

    Article  CAS  PubMed  Google Scholar 

  • Tanaka K, Miyake Y, Fukushima W et al (2011) Intake of Japanese and Chinese teas reduces risk of Parkinson’s disease. Parkinsonism Relat Disord 17:446–450

    Article  PubMed  Google Scholar 

  • Tanner CM, Aston DA (2000) Epidemiology of Parkinson’s disease and akinetic syndromes. Curr Opin Neurol 13:427–430

    Article  CAS  PubMed  Google Scholar 

  • Tykocki T, Kornakiewicz A, Mandat T et al (2013) Pain perception in patients with Parkinson’s disease. J Clin Neurosci 20:663–666

    Article  PubMed  Google Scholar 

  • Valldeoriola F, Gaig C, Muxi A et al (2011) 123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations. J Neurol 258:1126–1132

    Article  PubMed Central  PubMed  Google Scholar 

  • Varilla V, Samala RV, Galindo D et al (2011) Nocturia in the elderly: a wake-up call. Cleve Clin J Med 78:757–764

    Article  PubMed  Google Scholar 

  • Wang G, Cheng Q, Zheng R et al (2006) Economic burden of Parkinson’s disease in a developing country: a retrospective cost analysis in Shanghai, China. Mov Disord 21:1439–1443

    Article  PubMed  Google Scholar 

  • Wang G, Hong Z, Cheng Q et al (2009) Validation of the Chinese non-motor symptoms scale for Parkinson’s disease: results from a Chinese pilot study. Clin Neurol Neurosurg 111:523–526

    Article  PubMed  Google Scholar 

  • Wang C, Cai Y, Zheng Z et al (2012) Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants. Parkinsonism Relat Disord 18:958–963

    Article  PubMed  Google Scholar 

  • Yu B, Xiao ZY, Li JZ et al (2010) Study of an integrated non-motor symptoms questionnaire for Parkinson’s disease. Chin Med J (Engl) 123:1436–1440

    Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the National Basic Research Development Program of China (2011CB504101), and the Beijing high standard health human resource cultural program in health system (2009e1e12).

Conflict of interest

No potential conflicts of interest were disclosed.

Author information

Authors and Affiliations

  1. Department of Neurology, Neurobiology and Geriatrics, National GCP Clinical Trial Center on Neurodegenerative Disease, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, #45 Changchun Street, Beijing, 100053, China

    Da-Wei Li, Zhuqin Gu, Chaodong Wang, Jinghong Ma & Piu Chan

  2. Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China

    Da-Wei Li, Jinghong Ma & Piu Chan

  3. Key Laboratory of Neurodegenerative Disease, Ministry of Education and Key Laboratory for Parkinson’s Disease, Beijing, Beijing, 100053, China

    Zhuqin Gu, Chaodong Wang, Jinghong Ma & Piu Chan

  4. Department of Neurology, Xiangya Hospital of Central South University, Changsha, China

    Bei-Sha Tang

  5. Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China

    Sheng-Di Chen

Authors
  1. Da-Wei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhuqin Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chaodong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jinghong Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bei-Sha Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sheng-Di Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Piu Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Piu Chan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, DW., Gu, Z., Wang, C. et al. Non-motor symptoms in Chinese Parkinson’s disease patients with and without LRRK2 G2385R and R1628P variants. J Neural Transm 122, 661–667 (2015). https://doi.org/10.1007/s00702-014-1281-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-014-1281-4

Keywords

Search

Navigation